The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Alicia Morgans Employment - Dana-Farber Cancer Institute Stock and Other Ownership Interests - Vertex (I) Honoraria - Advanced Accelerator Applications; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Curium Pharma; Exelixis; Janssen; Lantheus Medical Imaging; Macrogenics; Merck; Novartis; Pfizer; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Johnson & Johnson/Janssen; Lantheus Medical Imaging; Merck; Novartis; Sumitomo Pharma Oncology Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Exact Sciences; Myovant Sciences; Pfizer; Sumitomo Pharma Oncology Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Novartis; Novartis; Pfizer   Nasreen Khan Employment - Bayer; Gilead Sciences (I) Travel, Accommodations, Expenses - Bayer   Mercedeh Ghadessi Employment - Bayer HealthCare Pharmacuticals Stock and Other Ownership Interests - Bayer HealthCare Pharmacuticals   Rana McKay Consulting or Advisory Role - Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol Myers Squibb; Calithera Biosciences; Caris Life Sciences; Daiichi Sankyo; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Precede Bio; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)   Guifang Chen Employment - Bayer Stock and Other Ownership Interests - Bayer   Daniel George Leadership - Capio BioSciences Stock and Other Ownership Interests - BMS; Pfizer Honoraria - Astellas Pharma; AstraZeneca; Axess Oncology; Bayer; Candel Therapeutics; Eisai; IDEOlogy Health; Janssen Oncology; Merck; Millennium Medical Publishing; Novartis; OncLive; Pfizer; Sumitomo; UroToday Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Candel Theraputics; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Novartis; Pfizer; Physicans' Education Resource Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Convergent Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst) Expert Testimony - Exelixis Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Novartis; Pfizer